Navigation Links
Deep Brain Stimulation Studied for Alzheimer's
Date:8/14/2010

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Aug. 11 (HealthDay News) -- In an extremely small, early trial, deep brain stimulation appeared to improve memory slightly in several patients with mild Alzheimer's disease.

The authors caution that the findings are very preliminary and that "no clear clinical benefit can be claimed" from the study. However, test results and brain imaging suggest that the procedure may one day hold some promise for the incurable illness, experts said.

"We don't want to overinterpret the results and I agree with the cautions on the one hand, but on the other hand the fact that the PET-scanning data looks so good seems pretty exciting to me," said Dr. Richard Lipton, an attending neurologist at Montefiore Medical Center in New York City and principal investigator of the Einstein Aging Study who was not involved in the deep brain stimulation research.

"Alzheimer's is not a disorder where you break even. It's a disorder where you decline . . . This is not the natural history of Alzheimer's. A successful treatment will leave you one year later where you were when you started," he added.

Deep brain stimulation is already used for people with other neurodegenerative diseases, most notably Parkinson's.

The way the Alzheimer's research came into being was a study in serendipity. In 2003, the same research group was working in a different area: using deep brain stimulation in an attempt to control appetite in an obese patient. The results had an unexpected benefit.

"We tested implanting an electrode in the areas of the brain that controlled appetite while [he was] awake," said Dr. Andres M. Lozano, senior author of a paper appearing in the Annals of Neurology. "While we were inserting the electrodes and turning them on, to our surprise, we were able to unlock some memories of events that happened over 30 years ago in this particular man."

Over time, the researchers also found "important improvements on the performance on memory tests" in this one test patient, said Lozano, who is chairman of neurosurgery at the University of Toronto and Canada Research Chair in Neuroscience.

Based on that discovery, Lozano decided to embark on a study involving Alzheimer's patients. The current phase 1 safety study was a small one, involving only six patients who for 12 months had electrodes planted in and continuously stimulating areas of the brain known to affect memory. All patients stayed on Alzheimer's medications throughout the trial.

"We used two Alzheimer's [measurement] scales commonly used. We expect patients to worsen on these scales over a year," Lozano said. "But we found that some patients did not worsen; some actually improved in their cognitive function."

And in the areas of the brain which are damaged by Alzheimer's, imaging scans turned up heightened glucose metabolism, indicating a higher level of brain activity, Lozano said.

"They're still open for business. They can still be used and activated," he said.

Patients with milder forms of Alzheimer's seemed to benefit the most from the deep brain stimulation.

The procedure seems to work by driving the activity in less-damaged areas of the brain, "reactivating these brain circuits that are responsible and cognitive functioning," Lozano explained.

In the small trial, the procedure appeared to be safe, with none of the patients showing weight changes, sleep disturbances or body chemistry abnormalities after the initial surgery, according to the researchers.

However, Lipton noted that deep brain stimulation is an invasive technique. "This is not a procedure free of risk," he said. "It involves taking often frail, older adults and drilling a hole through the skull, then pressing a needle through the tissue of the brain till the tip gets into a crucial area where you want to leave it. If you go through a blood vessel, you can produce bleeding that can cause serious harm. This is not a benign procedure."

Lipton added that the device would have to be approved before it is available for widespread use.

The researchers are now embarking on a larger, phase 2 study.

Lozano also reported a potential conflict of interest, which is that he holds intellectual property in the field of deep brain stimulation (DBS).

More information

The Mayo Clinic has more on deep brain stimulation.

SOURCES: Andres M. Lozano, M.D., Ph.D., chairman, division of neurosurgery, University of Toronto and Canada Research Chair in Neuroscience, Canada; Richard Lipton, M.D., attending neurologist, Montefiore Medical Center, professor and vice chair, neurology, Albert Einstein College of Medicine, and principal investigator, Einstein Aging Study; July 30, 2010, Annals of Neurology online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Menstrual Cramps May Alter Womens Brains
2. Menstrual cramps may alter brain structure
3. NIH award will enable design of brain tumor treatment that captures migrating cancer cells
4. Chemical system in brain behaves differently in cocaine addicts, UT Southwestern scientists find
5. Brain responds same to acute and chronic sleep loss
6. Brains wiring: More network than pyramid?
7. Better understanding of mapmaking in the brain
8. Type 2 Diabetes Might Harm Young Brain, Study Suggests
9. Brain study shows that thinking about God reduces distress -- but only for believers
10. Culture wires the brain: A cognitive neuroscience perspective
11. New diagnostic chip able to generate single-cell molecular fingerprints for brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Deep Brain Stimulation Studied for Alzheimer's
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: